Joshua Fitch, Senior Editor

Nirsevimab was approved by the FDA on July 17, 2023, ahead of the traditional RSV season, though in October, the Centers for Disease Control and Prevention (CDC) recommended it be prioritized for the highest-risk infants amid limited availability.

Gluten-free meal plans can be a critical treatment option and necessity for those with celiac disease. But for children with no medical conditions or restrictions? A gluten-free diet should not be the mainstay diet.

Vivian Hernandez-Truillo, MD, FAAP, FAAAAI, FACAAI; and Theresa Bingemann, MD, provide reaction and commentary regarding recently FDA-approved dupilumab to treat EoE in pediatric patients aged 1 to 11 years.

Deborah Persaud, MD, discusses the background and lead-up to her study examining very early ART in neonates born with HIV-1 and if this treatment could be a step towards ART-free treatment.

Take this quiz and test your knowledge of the American Academy of Pediatrics' recommendations for routine use of influenza vaccines, medications for the prevention and treatment of pediatric influenza.

Based on results from a recent C.S. Mott Poll on Children's Health, parents revealed their own goal-setting helped their children in working toward their respective goals.

There are reports that prophylaxis with ibuprofen in the first 12 to 24 hours of life can reduce the risk of severe intraventricular hemorrhage and pulmonary hemorrhage. However, it has not been found to increase survival without neurosensory impairment at 18 months.

The approach can improve mental health and various subgroups such as cognitive function, psychological well-being, and more.

Though revisions have been made to the emergency use authorization (EUA), the FDA stated in a press release that the EUA will continue to authorize emergency use in children aged 12 years and older who are at high risk of severe COVID-19.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

In this Contemporary Pediatrics Q+A interview, Weily Soong, MD, breaks down FDA-approved tralokinumab-ldrm for patients aged 12 to 17 years with moderate-to-severe atopic dermatitis.

Take this Contemporary Pediatrics quiz, and see if you can correctly diagnose the patient in this case study. Submit your answer to see if you were correct.

Tina Tan, MD, FAAP, FIDSA, FPIDS, tells Contemporary Pediatrics, “This is not new and demonstrates what is known, in that if vaccination rates do not stay at a level that is protective, outbreaks of vaccine preventable diseases will occur.”

The approval makes dupilumab the first and only treatment specifically indicated for eosinophilic esophagitis (EoE) patients aged 1 to 11 years that weigh at least 33 lbs (15 kg).

In 2021, current-use prevalence of cannabis was lower among male students compared to female students for the first time. This led investigators to conclude that developing interventions that consider protective factors by sex or gender could lead to equity in cannabis reduction strategies among youth.

“In pediatric patients, we know that there will be increased scar tissue formation, so it is even more necessary to prevent and reduce the residual burn scars,” Stan Monstrey, former secretary general, president, European Association of Plastic Surgeons, told Contemporary Pediatrics.

Decreasing severe adverse safety events (ASEs) could improve the poor outcomes associated with children with out-of-hospital cardiac arrest (OHCA), since 60% had at least 1 ASE.

Investigators of a new study published in JAMA Pediatrics concluded that maternal vaccination was safe with regard to neurodevelopment of the child at ages 12 months and 18 months.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Though the association of BMI gain and 100% fruit juice in children was “small,” authors concluded their findings support public health guidance to limit consumption of the beverage to prevent overweight and obesity.

In this Contemporary Pediatrics interview, Ari Brown, MD, FAAP, details the benefits of goat milk-based infant formula, discusses FDA authorized Kabrita goat milk-based infant formula, and highlights misconceptions associated with goat milk-based formula.

Investigators of a study published in Annals of Internal Medicine concluded that the BNT162b2 COVID-19 vaccine demonstrated efficacy against the Delta and Omicron variants of COVID-19 in children and adolescents, offering new, extended follow-up period data.

In this Contemporary Pediatrics interview, Steven Selbst, MD, talks about how preventable unintentional firearm injuries in children can be, as he references an uptick in these cases in his emergency department.

Main factors contributing to the hospitalization of pediatric patients with influenza A were abdominal pain, viral co-infection and some hematological abnormalities.

According to new pooled individual patient responses, roflumilast cream 0.15% treatment led nearly 92% of individuals to achieve a measurable improvement in the Eczema Area and Severity Index.

“I think these injuries in particular are tragic, these unintentional ones, because they are preventable,” said Steven Selbst, MD. “If parents would lock the gun or keep the gun stored without the ammunition, it would be preventable, but parents don't do that.”

Seborrheic dermatitis patients with an inadequate response or intolerance to steroids were 3.5 times more likely to achieve Investigator Global Assessment (IGA) success with roflumilast foam 0.3% compared to vehicle, new data from the 2024 Winter Clinical Dermatology Conference revealed.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Steven Selbst, MD, provides an update as to what he is seeing in the emergency department related to influenza, RSV, and COVID-19.

New interim data from the on-going, long-term extension ADORING 3 study and from an integrated analysis of the entire ADORING development program revealed efficacy and safety using tapinarof cream 1% continued beyond 8 weeks of treatment.